A Hybrid Nanosystem for Prostate Cancer Therapy: Codelivery of Enzalutamide and Curcumin via Selenium-Embedded Mesoporous Silica and Chitosan Nanoparticles.

Tavakoli Z, Khajeh K, Ranjbar B.

Open source

DOI
10.1002/open.202500589
Published
2026-03-01
Container
ChemistryOpen
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/open.202500589,
  title = {A Hybrid Nanosystem for Prostate Cancer Therapy: Codelivery of Enzalutamide and Curcumin via Selenium-Embedded Mesoporous Silica and Chitosan Nanoparticles.},
  author = {Tavakoli Z and  Khajeh K and  Ranjbar B.},
  year = {2026},
  journal = {ChemistryOpen},
  doi = {10.1002/open.202500589},
  url = {https://doi.org/10.1002/open.202500589}
}

RIS

TY  - JOUR
TI  - A Hybrid Nanosystem for Prostate Cancer Therapy: Codelivery of Enzalutamide and Curcumin via Selenium-Embedded Mesoporous Silica and Chitosan Nanoparticles.
AU  - Tavakoli Z
AU  -  Khajeh K
AU  -  Ranjbar B.
PY  - 2026
JO  - ChemistryOpen
DO  - 10.1002/open.202500589
UR  - https://doi.org/10.1002/open.202500589
ER  - 

APA

Z, T., K, K., & B., R. (2026). A Hybrid Nanosystem for Prostate Cancer Therapy: Codelivery of Enzalutamide and Curcumin via Selenium-Embedded Mesoporous Silica and Chitosan Nanoparticles.. ChemistryOpen. https://doi.org/10.1002/open.202500589

Source records